Treatment Plan for Recurrent UTIs (≥3 UTIs/year or ≥2 in 6 months)
For an otherwise healthy adult with recurrent UTIs meeting these criteria, implement a stepwise prevention strategy starting with non-antibiotic measures, reserving continuous antibiotic prophylaxis (6-12 months duration) only when non-antimicrobial interventions fail. 1
Acute Episode Treatment
When an acute UTI occurs, treat with standard short-course antibiotics:
For Women:
- First-line options:
- Fosfomycin trometamol 3g single dose
- Nitrofurantoin 100mg twice daily for 5 days
- Pivmecillinam 400mg three times daily for 3-5 days 1
For Men:
- Trimethoprim-sulfamethoxazole 160/800mg twice daily for 7 days (not 3 days as in women) 1
- Fluoroquinolones may be used based on local susceptibility patterns
Critical point: Always obtain urine culture before treatment in recurrent UTI patients to guide therapy 1
Prevention Strategy: Stepwise Approach
Step 1: Non-Antibiotic Prophylaxis (Try First)
Strong recommendations:
- Immunoactive prophylaxis (all age groups) 1
- Vaginal estrogen (postmenopausal women only) 1
- Methenamine hippurate (women without urinary tract abnormalities) 1
Weak recommendations (discuss limitations with patient):
- Increased fluid intake (premenopausal women) 1
- Probiotics with proven vaginal flora efficacy 1
- Cranberry products (evidence quality is low and contradictory) 1, 2
- D-mannose (weak and contradictory evidence) 1
Step 2: Antibiotic Prophylaxis (When Non-Antibiotic Measures Fail)
Dosing options:
Continuous daily prophylaxis:
- Nitrofurantoin 50-100mg daily
- Trimethoprim 100mg daily
- Trimethoprim-sulfamethoxazole 40/200mg daily
- Cephalexin 125-250mg daily 2
Postcoital prophylaxis (for UTIs temporally related to sexual activity):
- Same agents as above, single dose after intercourse
- Equally effective as daily dosing with fewer side effects 2, 3
Alternative:
- Fosfomycin 3g every 10 days 2
Step 3: Self-Administered Treatment (For Compliant Patients)
Patients with good compliance can use short-term self-administered antimicrobial therapy at first symptom onset 1
Monitoring During Prophylaxis
- Periodic assessment every 3-6 months while on prophylaxis 2
- Counsel patients about side effects:
Important Caveats
Do NOT perform extensive workup (cystoscopy, full abdominal ultrasound) in women younger than 40 years with recurrent UTI and no risk factors 1
Recognize when to escalate: If patient has repeated pyelonephritis (not just cystitis), consider complicated etiology and investigate further 1
Antibiotic stewardship: The benefit of prophylaxis lasts only during active intake; UTI recurrence returns to baseline after cessation 2. Some patients remain on prophylaxis for years without adverse events, though this lacks evidence-based support 2.
Post-treatment: Do NOT routinely check for asymptomatic bacteriuria after treatment—it does not require treatment 1